Labnovation 20 Test Influenza AB Test Kit For Early Treatment

Product Specification

Rapid Test Kit Antigen & Influenza Rapid Test SARS-CoV-2 Antigen And Influenza A/B Rapid Test Kit
Intended Use
The rapid Test Kit is intended for the qualitative detection and differentiation of nucleocapsid protein antigens from SARS-CoV-2, influenza type A and influenza type B in the same time directly from nasal/nasopharyngeal (NS/NP) swab, oropharyngeal (OP) swab and saliva specimens from patients with signs and symptoms of respiratory viral infection. It is for professional use only. It is an aid in the diagnosis of the patients with suspected SARS-CoV-2 or influenza infection in conjunction with clinical presentation and results of other laboratory tests. Results from this test kit should not be used as the sole basis for diagnosis.
 
Specification

Main Components

• 20 Test cassettes
• 2 Sample extraction Buffers
• 20 Sample tubes
• 20 Swabs
• 1 Tube Stand
• 1 Instruction Manual

Feature

• Short test time, within 15 minutes
• Easy operation, One-step solution
• High accuracy, sensitivity and specificity
• Lower cost with high efficiency

Sample Collection
 

• Nasopharyngeal swab:The sampler gently holds the head of the person to be collected with one hand, holds the swab with the other hand, sticks the swab to the nostril to enter, and slowly penetrates backwards along the bottom of the lower nasal passage, so as not to exert too much force to avoid traumatic hemorrhage. When the tip of the swab reaches the posterior wall of the nasopharynx cavity, gently rotate it for one week and then slowly take out the swab.
• Oropharyngeal swab: The head of the person to be collected is slightly tilted and his mouth is wide open, exposing the pharyngeal tonsils on both sides. Wipe the swab across the root of the tongue. Wipe the pharyngeal tonsils on both sides of the person to be collected back and forth with a little force for at least 3 times, and then wipe up and down the posterior pharyngeal wall for at least 3 times.

Sample Treatment

Add 550μl sample extraction(about 22-24 drops) into the sample tube, dip the swab after collecting the sample into the sample extraction liquid, fully immerse the tip of the swab, rotate and squeeze the swab 10 times, then pull out the swab, and take the stranded liquid as the sample to test cassette.
 
Use  Step

• Take out the test cassette from the sealed pouch, place it on a clean and level surface with the sample port well up.

• Apply 2 full drops of the treated sample (60μl-70μl) vertically into each of the two sample wells of the test cassette.

• Observe the test results immediately within 15~20 minutes, the result is invalid over 20 minutes.

 
Interpretation Of Result

• POSITIVE: The presence of T (T on nCoV /A or B on Flu) and C lines within the reaction window indicate a positive result on SARS-CoV-2 or Flu A and/or B infection or co-infection.

• NEGATIVE: One colored line appears in the control region(C). No apparent colored line appears in the test region (T on nCoV /A or B on Flu). The negative result does not indicate the absence of analytes in the sample, it only indicates the level of tested analytes in the sample is less than the minimum detection limit

• INVALID: No colored lines appear, or control line fails to appear, indicating that the operator error or reagent failure. Verify the test procedure and repeat the test with a new testing device.

Other Information

• This reagent is a qualitative detection reagent, which cannot determine the exact content of antigen.
• The test results of this reagent are only for the reference of clinicians and should not be taken as the sole basis for clinical diagnosis and treatment. Clinical management of patients should be considered in the light of their symptoms/signs, medical history, other laboratory tests and treatment responses.
• False negative results may be caused by unreasonable sample collection, transport and treatment, and low viral load in samples.